88 related articles for article (PubMed ID: 16034482)
41. [PPARgamma-gene therapy].
Katayama K; Nakajima A
Nihon Rinsho; 2010 Feb; 68(2):356-60. PubMed ID: 20158109
[TBL] [Abstract][Full Text] [Related]
42. Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.
Villapol S
Cell Mol Neurobiol; 2018 Jan; 38(1):121-132. PubMed ID: 28975471
[TBL] [Abstract][Full Text] [Related]
43. Biology of PPAR gamma in cancer: a critical review on existing lacunae.
Krishnan A; Nair SA; Pillai MR
Curr Mol Med; 2007 Sep; 7(6):532-40. PubMed ID: 17896990
[TBL] [Abstract][Full Text] [Related]
44. The role of PPARγ in prostate cancer development and progression.
Hartley A; Ahmad I
Br J Cancer; 2023 Apr; 128(6):940-945. PubMed ID: 36510001
[TBL] [Abstract][Full Text] [Related]
45. Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.
Cohen SM
Toxicol Sci; 2005 Oct; 87(2):322-7. PubMed ID: 16049269
[No Abstract] [Full Text] [Related]
46. PPARgamma: a novel molecular target in lung disease.
Hart CM; Roman J; Reddy R; Sime PJ
J Investig Med; 2008 Feb; 56(2):515-7. PubMed ID: 18317433
[TBL] [Abstract][Full Text] [Related]
47. [Structural insights of PPARgamma].
Kato S; Takada I
Nihon Rinsho; 2010 Feb; 68(2):176-9. PubMed ID: 20158081
[No Abstract] [Full Text] [Related]
48. [Present understanding of intracellular signal transduction of interleukin-1].
Li XM; Li B
Sheng Li Ke Xue Jin Zhan; 1998 Jan; 29(1):59-62. PubMed ID: 12501708
[No Abstract] [Full Text] [Related]
49. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story.
François M; Richette P; Corvol MT
Drug News Perspect; 2005 May; 18(4):257-61. PubMed ID: 16034482
[TBL] [Abstract][Full Text] [Related]
50. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
Park SJ; Lee YC
J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
[TBL] [Abstract][Full Text] [Related]
51. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Belvisi MG; Hele DJ; Birrell MA
Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
[TBL] [Abstract][Full Text] [Related]
52. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
[TBL] [Abstract][Full Text] [Related]
53. Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma.
Kim SR; Lee KS; Park HS; Park SJ; Min KH; Jin SM; Lee YC
Mol Pharmacol; 2005 Dec; 68(6):1568-75. PubMed ID: 16150927
[TBL] [Abstract][Full Text] [Related]
54. Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species.
Jung Y; Song S; Choi C
Immunol Lett; 2008 Apr; 117(1):63-9. PubMed ID: 18206249
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
